Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study.

[1]  M. Fujisawa,et al.  Excellent results with high-dose mizoribine combined with cyclosporine, corticosteroid, and basiliximab in renal transplant recipients: multicenter study in Japan. , 2012, Transplantation proceedings.

[2]  R. Vijayaraghavan,et al.  Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders. , 2008, Transplantation proceedings.

[3]  P. Kes,et al.  Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation? , 2005, Transplantation proceedings.

[4]  S. Takahara,et al.  Mizoribine in combination therapy with tacrolimus for living donor renal transplantation: analysis of a nationwide study in Japan. , 2004, Transplantation proceedings.

[5]  A. Jain,et al.  No myelosuppression when mizoribine is combined with allopurinol for the treatment of hyperuricemia in renal transplant patients , 2001, Clinical and Experimental Nephrology.

[6]  C. Payá,et al.  Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients , 2000, Clinical transplantation.

[7]  H. Ishikawa.  Mizoribine and mycophenolate mofetil. , 1999, Current medicinal chemistry.

[8]  S. Takahara,et al.  Effects of cyclosporine, azathioprine, mizoribine, and prednisolone on replication of human cytomegalovirus. , 1990, Transplantation proceedings.

[9]  M. Takada,et al.  STUDIES ON BREDININ. I , 1974 .

[10]  M. Takada,et al.  Studies on bredinin. I. Isolation, characterization and biological properties. , 1974, The Journal of antibiotics.